久光製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/06/15 | 5,780 | 5,890 | 5,780 | 5,860 | +90 | +1.6% | 98,500 |
2021/06/14 | 5,800 | 5,850 | 5,730 | 5,770 | -50 | -0.9% | 77,400 |
2021/06/11 | 5,870 | 5,890 | 5,780 | 5,820 | ±0 | ±0% | 128,000 |
2021/06/10 | 5,780 | 5,910 | 5,780 | 5,820 | +10 | +0.2% | 123,300 |
2021/06/09 | 5,810 | 5,860 | 5,790 | 5,810 | +30 | +0.5% | 78,200 |
2021/06/08 | 5,740 | 5,870 | 5,730 | 5,780 | +70 | +1.2% | 114,200 |
2021/06/07 | 5,750 | 5,790 | 5,670 | 5,710 | -90 | -1.6% | 105,900 |
2021/06/04 | 5,850 | 5,900 | 5,800 | 5,800 | -20 | -0.3% | 69,400 |
2021/06/03 | 5,840 | 5,960 | 5,790 | 5,820 | -70 | -1.2% | 131,500 |
2021/06/02 | 5,990 | 5,990 | 5,890 | 5,890 | -150 | -2.5% | 114,200 |
2021/06/01 | 6,040 | 6,070 | 5,930 | 6,040 | +40 | +0.7% | 90,000 |
2021/05/31 | 6,110 | 6,200 | 6,000 | 6,000 | -110 | -1.8% | 83,200 |
2021/05/28 | 6,090 | 6,150 | 6,050 | 6,110 | +60 | +1% | 98,000 |
2021/05/27 | 6,120 | 6,190 | 6,050 | 6,050 | -70 | -1.1% | 191,800 |
2021/05/26 | 6,100 | 6,180 | 6,080 | 6,120 | -10 | -0.2% | 80,100 |
2021/05/25 | 6,230 | 6,230 | 6,090 | 6,130 | -110 | -1.8% | 89,500 |
2021/05/24 | 6,240 | 6,310 | 6,240 | 6,240 | -30 | -0.5% | 74,400 |
2021/05/21 | 6,350 | 6,390 | 6,250 | 6,270 | -20 | -0.3% | 88,700 |
2021/05/20 | 6,300 | 6,400 | 6,280 | 6,290 | ±0 | ±0% | 73,400 |
2021/05/19 | 6,300 | 6,350 | 6,230 | 6,290 | -110 | -1.7% | 79,700 |
2021/05/18 | 6,290 | 6,470 | 6,280 | 6,400 | +120 | +1.9% | 83,200 |
2021/05/17 | 6,290 | 6,330 | 6,200 | 6,280 | +40 | +0.6% | 95,100 |
2021/05/14 | 6,190 | 6,310 | 6,190 | 6,240 | +80 | +1.3% | 113,300 |
2021/05/13 | 6,190 | 6,250 | 6,130 | 6,160 | -70 | -1.1% | 90,000 |
2021/05/12 | 6,420 | 6,430 | 6,200 | 6,230 | -210 | -3.3% | 131,500 |
2021/05/11 | 6,530 | 6,600 | 6,400 | 6,440 | -120 | -1.8% | 109,400 |
2021/05/10 | 6,500 | 6,590 | 6,480 | 6,560 | +50 | +0.8% | 63,000 |
2021/05/07 | 6,490 | 6,650 | 6,470 | 6,510 | +70 | +1.1% | 127,600 |
2021/05/06 | 6,410 | 6,570 | 6,410 | 6,440 | +80 | +1.3% | 103,700 |
2021/04/30 | 6,340 | 6,460 | 6,310 | 6,360 | +20 | +0.3% | 115,300 |
2021/04/28 | 6,400 | 6,420 | 6,320 | 6,340 | -60 | -0.9% | 74,900 |
2021/04/27 | 6,520 | 6,520 | 6,370 | 6,400 | -130 | -2% | 90,400 |
2021/04/26 | 6,540 | 6,570 | 6,450 | 6,530 | -10 | -0.2% | 79,400 |
2021/04/23 | 6,510 | 6,570 | 6,510 | 6,540 | -40 | -0.6% | 70,300 |
2021/04/22 | 6,540 | 6,590 | 6,450 | 6,580 | +130 | +2% | 106,000 |
2021/04/21 | 6,440 | 6,480 | 6,390 | 6,450 | -140 | -2.1% | 119,000 |
2021/04/20 | 6,620 | 6,630 | 6,540 | 6,590 | -20 | -0.3% | 104,400 |
2021/04/19 | 6,700 | 6,720 | 6,610 | 6,610 | -100 | -1.5% | 93,800 |
2021/04/16 | 6,740 | 6,740 | 6,620 | 6,710 | -30 | -0.4% | 77,200 |
2021/04/15 | 6,680 | 6,780 | 6,640 | 6,740 | +50 | +0.7% | 87,500 |
2021/04/14 | 6,670 | 6,730 | 6,640 | 6,690 | -80 | -1.2% | 156,700 |
2021/04/13 | 6,790 | 6,890 | 6,760 | 6,770 | +40 | +0.6% | 139,900 |
2021/04/12 | 6,830 | 6,840 | 6,630 | 6,730 | -20 | -0.3% | 165,100 |
2021/04/09 | 6,890 | 6,920 | 6,740 | 6,750 | -200 | -2.9% | 214,400 |
2021/04/08 | 7,000 | 7,010 | 6,810 | 6,950 | ±0 | ±0% | 135,500 |
2021/04/07 | 7,020 | 7,070 | 6,910 | 6,950 | -60 | -0.9% | 127,100 |
2021/04/06 | 7,240 | 7,290 | 6,970 | 7,010 | -290 | -4% | 138,000 |
2021/04/05 | 7,320 | 7,320 | 7,190 | 7,300 | ±0 | ±0% | 53,400 |
2021/04/02 | 7,230 | 7,320 | 7,210 | 7,300 | +160 | +2.2% | 53,400 |
2021/04/01 | 7,240 | 7,260 | 7,120 | 7,140 | -70 | -1% | 88,300 |
951~
1000
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「久光薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
久光薬 | 443,700円 | +5.8% | +1.2% | 2.70% | 14.72倍 | 1.17倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
ロート | 241,800円 | +18.2% | +4.2% | 1.49% | 16.97倍 | 2.16倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
参天薬 | 147,400円 | 0.0% | +50.6% | 2.44% | 15.48倍 | 1.74倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
住友ファーマ | 94,100円 | +26.8% | - | 0.00% | 15.84倍 | 3.27倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
ツムラ | 430,100円 | +20.9% | +87.3% | 3.16% | 9.61倍 | 1.11倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
市場注目の銘柄
チャート関連のコラム